Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy.
Saved in:
| Title: | Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy. |
|---|---|
| Authors: | Shapiro NL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Mak E; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Tsvetanov KA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Department of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK., Goddard J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Vontobel DS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK., Durcan R; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Chouliaras L; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Fryer T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Hong YT; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Aigbirhio F; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, CB2 0QQ, UK., Heslegrave A; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK., Franzmeier N; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden., Brendel M; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.; Institute for Stroke and Dementia Research (iSD), University Hospital, Ludwig-Maximilians-Universität, Munich, 81377, Germany.; Bavarian Cancer Research Center (BZKF), Partner Site Munich, Munich, 80539, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between German Cancer Research Center (DKFZ) and LMU Munich, Munich, 80366, Germany.; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich 81377, Germany.; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, 81377, Germany., Zetterberg H; UK Dementia Research Institute and Department of Neurodegenerative Disease at UCL, London, NW1 3BT, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, 431 39, Sweden.; Department of Neurodegenerative Disease, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, 405 30, Sweden.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China., O'Brien JT; Department of Psychiatry, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB2 0SZ, UK., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.; Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK., Malpetti M; Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.; UK Dementia Research Institute at the University of Cambridge, Cambridge, CB2 0AH, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. |
| Source: | Brain communications [Brain Commun] 2025 Nov 27; Vol. 7 (6), pp. fcaf467. Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2632-1297 |
|---|---|
| DOI: | 10.1093/braincomms/fcaf467 |
